3FY-29211-81327
2 vaccinations
1 coded response
8 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 381 / TN
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Registered in v-safe
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Fatigue, Headache, Injection site discomfort, Myalgia, Pyrexia, Tachycardia — Feeling: Fair · Headache, Fatigue or tirednessFree text: I did not get to discuss symptoms right after the shots. After the first dose on 12/18/2020, I had some soreness at the injection site about 12 hours postinjection. After the second dose on 1/8/2021, I had a headache about 3 hours after receiving the second shot. Starting 22 hours post injection and ending approximately 36 hours post injection, I had fever, headache, chills, myalgias, fatigue, and tachycardia. My fever went out to 101.5. My heart rate was as high as 115.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
- 2021-01-15
- 2021-01-24
- 2021-01-31
- 2021-04-09
- 2021-07-11
- 2022-01-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): I did not get to discuss symptoms right after the shots. After the first dose on 12/18/2020, I had some soreness at the injection site about 12 hours postinjection. After the second dose on 1/8/2021, I had a headache about 3 hours after receiving the second shot. Starting 22 hours post injection and ending approximately 36 hours post injection, I had fever, headache, chills, myalgias, fatigue, and tachycardia. My fever went out to 101.5. My heart rate was as high as 115.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release